[Temporary Announcement] Jinbo Biotech: Statement and Commitment of Independent Director Candidate (Deng Zelin)

Securities code: 832982 Securities abbreviation: Jinbo Biotechnology Announcement number: 2025-151 Shanxi Jinbo Biopharmaceutical Co., Ltd.

Statement and Commitment of Independent Director Candidate (Deng Zelin)

The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete, and that there are no false records, misleading statements or major omissions, and bear individual and joint legal liability for the authenticity, accuracy and completeness of the contents.

I, Deng Zelin, have fully understood and agreed to be nominated by the nominator, the Board of Directors of Shanxi Jinbo Biopharmaceutical Co., Ltd., as an independent director candidate for the fourth session of the Board of Directors of Shanxi Jinbo Biopharmaceutical Co., Ltd. I publicly declare that I have the qualifications to serve as an independent director and guarantee that there is no relationship that would affect my independence as an independent director of Shanxi Jinbo Biopharmaceutical Co., Ltd. My specific statement and commitment are as follows:

1. I have met the following conditions at the same time:

(1) Have basic knowledge of the operation of listed companies, and be familiar with relevant laws and regulations, departmental rules, normative documents and business rules of the Beijing Stock Exchange;

(2) Have more than five years of legal, accounting or economic work experience necessary to perform the duties of an independent director;

(3) Have good personal moral character and have no bad records such as major breach of trust;

(4) Other conditions specified by the Beijing Exchange.

2. My qualifications meet the requirements of the following laws, regulations, departmental rules and normative documents, as well as the business rules of the Beijing Stock Exchange:

(1) The provisions of the Company Law on the qualifications of directors;

(2) Relevant provisions of the Civil Servant Law of the People's Republic of China;

(3) Relevant provisions of the China Securities Regulatory Commission's "Measures for the Administration of Independent Directors of Listed Companies";

(4) Relevant regulations of the Central Commission for Discipline Inspection of the Communist Party of China and the Organization Department of the Central Committee of the Communist Party of China on "Notice on Regulating Central Management Cadres to Resign from Public Office or Serve as Independent Directors and Independent Supervisors of Listed Companies and Fund Management Companies after Retirement";

(5) Relevant regulations of the Organization Department of the Central Committee of the Communist Party of China on the "Opinions on Further Regulating Part-time Work (Office) of Party and Government Leading Cadres in Enterprises";

(6) Relevant provisions of the "Opinions on Strengthening Anti-corruption and Integrity Construction in Colleges and Universities" issued by the Central Commission for Discipline Inspection of the Communist Party of China, the Ministry of Education, and the Ministry of Supervision;

(7) Relevant provisions of the People's Bank of China's "Guidelines on the Independent Director and External Supervisor System of Joint-stock Commercial Banks";

(8) Relevant provisions of the China Securities Regulatory Commission's "Measures for the Supervision and Administration of Directors, Supervisors, Senior Managers and Practitioners of Securities Fund Business Institutions";

(9) Relevant regulations such as the "Measures for the Administration of the Qualifications of Directors (Councillors) and Senior Managers of Banking Financial Institutions", the "Management Regulations for the Qualifications of Directors, Supervisors and Senior Managers of Insurance Companies", "Measures for the Administration of Independent Directors of Insurance Institutions", etc.;

(10) Other situations stipulated in laws, regulations, departmental rules, normative documents and business rules of the Beijing Stock Exchange.

3. I am independent and do not fall into the following situations:

(1) Personnel working in listed companies or their affiliated enterprises and their spouses, parents, children, and major social relations;

(2) Natural person shareholders and their spouses, parents, and children who directly or indirectly hold more than 1% of the issued shares of a listed company or are among the top ten shareholders of a listed company;

(3) Shareholders who directly or indirectly hold more than 5% of the issued shares of a listed company or persons who serve in the top five shareholders of a listed company and their spouses, parents, and children;

(4) Personnel working in affiliated enterprises of the controlling shareholder or actual controller of a listed company and their spouses, parents, and children;

(5) Persons who have significant business dealings with listed companies, their controlling shareholders, actual controllers, or their respective subsidiaries, or persons who serve in units that have significant business dealings, their controlling shareholders, or actual controllers;

(6) Personnel who provide financial, legal, consulting, sponsorship and other services to listed companies, their controlling shareholders, actual controllers or their respective affiliated enterprises, including but not limited to all members of the project team of the intermediary agency providing services, reviewers at all levels, persons who signed the report, partners, directors, senior managers and principal persons in charge;

(7) Persons who have had the circumstances listed in items 1 to 6 in the past twelve months;

(8) Other personnel who are not independent as stipulated in laws, administrative regulations, provisions of the China Securities Regulatory Commission, the business rules of the Exchange and the company's articles of association.

The subsidiaries of the listed company's controlling shareholders and actual controllers in items 4 to 6 do not include enterprises controlled by the same state-owned asset management agency as the listed company and that do not have an affiliated relationship with the listed company in accordance with relevant regulations.

4. I do not have the following bad records:

(1) There are circumstances that prohibit you from serving as a director, supervisor, or senior manager as stipulated in the Company Law and other laws and regulations, departmental rules, etc.;

(2) The China Securities Regulatory Commission has taken measures to prohibit entry into the securities market and the time limit has not yet expired;

(3) The stock exchange or National Equities Exchange and Quotations Co., Ltd. determines that the person is not suitable to serve as a director, supervisor, or senior manager of the company, and the time limit has not yet expired;

(4) Subject to administrative penalties from the China Securities Regulatory Commission or criminal penalties from judicial authorities due to securities and futures violations in the past 36 months;

(5) Being investigated by the China Securities Regulatory Commission or judicial authorities for suspected securities and futures crimes, but no clear conclusion has been reached;

(6) Having been publicly condemned or criticized three or more times by the stock exchange or the National Equities Exchange and Quotations in the past 36 months;

(7) Bad records such as major breach of trust;

(8) During the previous period of serving as an independent director, the board of directors proposed to convene a shareholders' meeting to be removed from the position due to failure to attend in person twice in a row or entrusting other independent directors to attend board meetings on his behalf, and the period was less than 12 months;

(9) Other circumstances specified by the Beijing Exchange.

5. Including Shanxi Jinbo Biopharmaceutical Co., Ltd., the number of domestic listed companies for which I am an independent director does not exceed three, and I have not served in Shanxi Jinbo Biopharmaceutical Co., Ltd. for more than six consecutive years.

6. I do not have the following circumstances:

(1) During his previous term as an independent director, he failed to attend two consecutive board meetings in person or failed to attend in person the number of board meetings for 12 consecutive months exceeding one-half of the total number of board meetings during that period;

(2) Previous independent directors were removed from office in advance by the listed company before the expiration of their term;

(3) Has been punished by other relevant departments other than the China Securities Regulatory Commission within the last 36 months;

(4) Other circumstances that may affect the faithful, diligent and independent performance of duties by independent directors.

I have verified my qualifications as an independent director candidate in accordance with the "Beijing Stock Exchange Guidelines for Continuous Supervision of Listed Companies No. 1 - Independent Directors" and confirmed that I meet the requirements.

I am fully aware of the responsibilities of an independent director and guarantee that the above statement is true, complete and accurate, and does not contain any false statements or misleading elements. I fully understand the possible consequences of making false statements. Beijing Exchange can confirm my employment conditions and independence based on this statement.

I promise: While serving as an independent director of Shanxi Jinbo Biopharmaceutical Co., Ltd., I will abide by the requirements of laws, regulations, departmental regulations, normative documents and the business rules of the North Exchange, accept the supervision of the North Exchange, ensure that I have sufficient time and energy to perform my duties, make independent judgments, and will not be influenced by listed companies and their major shareholders, actual controllers and other units or individuals.

I promise: If I do not meet the independence conditions or qualifications of an independent director after taking office, I will resign as an independent director in accordance with relevant regulations.

Hereby declare.

Candidate: Deng Zelin

September 8, 2025